THYMOSIN ALPHA 1 10MG

Thymosin Alpha 1 (TA1) 10mg — Immune Modulation Research Peptide

Thymosin Alpha 1 (TA1) 10mg is a synthetic peptide of significant research interest, recognised for its capacity to modulate and enhance immune system function. Studies have demonstrated TA1's ability to stimulate T-cell activation, regulate broad immune responses, and support the body's innate defence mechanisms against a range of bacterial and viral challenges.

Research Applications

Investigations into Thymosin Alpha 1 have focused primarily on its immunomodulatory properties — particularly its role in promoting antiviral and antibacterial defences. Researchers have also explored its potential to reduce systemic inflammation, support recovery from infection, and improve immune resilience across subjects with compromised or dysregulated immune responses.

Formulation & Purity

Supplied as a high-purity white lyophilised powder, this product exceeds >99% purity as verified by HPLC analysis. Its freeze-dried formulation ensures long-term structural stability, maintaining peptide integrity throughout storage and transport. Researchers may reconstitute the compound using a sterile diluent of choice suited to their experimental protocol.

Intended Use

Thymosin Alpha 1 10mg is intended exclusively for in vitro and non-clinical scientific research. It is not approved for human or animal therapeutic, diagnostic, or medicinal use. All handling and experimentation must be conducted by trained professionals within appropriate controlled laboratory environments.

Ultima Labs